Johnson and Johnson Omnicare Kickback Whistleblower Suit To Continue Judge Says

A lawsuit filed against Johnson & Johnson by a whistleblower and the U.S. Department of Justice, alleging the company paid kickbacks to influence sales of its drugs will continue, says Federal Judge Richard Stearns. The company is alleged to have paid its kickbacks to Omnicare Inc. the largest U.S, pharmacy for nursing home patients, to influence it to sell J & J’s antipsychotic drug Risperdal. Whistleblowers Bernard Lisitza and David Kammerer sued under the False Claims Act. Lisitza is a former Omnicare pharmacist. The U.S. sued J & J last year, claiming they paid millions to induce Omnicare to buy recommended J & J drugs. Omnicare, based in Kentucky, paid $98 million in 2009 to settle civil claims by the U.S. and several states. J & J is arguing that it is common commercial practice to give customers high rebates based on the share of a manufacturer;s product used. The judge disagreed.

The URI to TrackBack this entry is: https://jeffreynewmanlaw.wordpress.com/2011/02/28/j-j-omnicare-kickback-whistleblower-suit-to-continue-judge-says/trackback/

RSS feed for comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: